Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

1.520 +0.080 (+5.57%)
Delayed Quote Updated: 2:26 PM EDT, Oct 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 78,446
Open 1.465
Bid (Size) 1.500 (100)
Ask (Size) 1.530 (800)
Prev. Close 1.440
Today's Range 1.430 - 1.588
52wk Range 1.170 - 13.25
Shares Outstanding 596,978
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series
From Enveric Biosciences
Via Business Wire

Performance

52-Week Range 88.5% below 52-week high
1.520
1.1752W Low 13.2552W High
1 Week
1.331W Low 1.451W High

Enveric Biosciences, Inc. - Common Stock (ENVB) traded between $1.17 and $13.25 over the past 52 weeks and last traded at $1.52, 88.5% below its 52-week high. Over the past week it ranged between $1.33 and $1.45.

Past 12 Months
+11.0%
-2.6%
+15.2%
-54.9%
-58.6%
-82.2%
1W +$0.15
1M -$0.04
3M +$0.20
6M -$1.85
YTD -$2.15
1Y -$7.04

ENVB was -82.2% over the past year, -54.9% over six months, -58.6% year to date, +11.0% in the last week.

12 Months vs Market
ENVB
-82.2%
DIA
+12.7%
SPY
+15.1%
QQQ
+18.5%
IWM
+11.3%

Over the past 12 months ENVB returned -82.2% versus DIA (Dow) +12.7%, SPY (S&P 500) +15.1%, QQQ (Nasdaq 100) +18.5% and IWM (Russell 2000) +11.3%.

Volume & Liquidity 0.82× 3-mo avg
Today 78,446 3-mo avg 96.2K
1W
54.1K
1M
64.0K
3M
96.2K
6M
623.7K
YTD
1.4M
1Y
1.2M

ENVB most recently traded 78,446 shares against a 3-month average daily volume of 96.2K.

More News

Read More
News headline image
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Announces Participation in 2026 BIO International Convention
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model
From Enveric Biosciences
Via Business Wire
These stocks are moving in today's session ↗
Via Chartmill
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
SmallCap Emerge: ENVB, SMX, ANY, ELPW Across High-Growth Sectors
Via AB Newswire
Topics Artificial Intelligence Economy
Top movers analysis one hour before the close of the markets on 2026-04-24: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Enveric Biosciences to Participate in a Panel Discussion at Needham’s Virtual Psychedelics Forum
From Enveric Biosciences
Via Business Wire
News headline image
Kartoon Studios (NYSE: TOON) Gaining Momentum Alongside CMND, ENVB, WLDS, ANY – See Why?
Via AB Newswire
Topics Intellectual Property
Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session. ↗
Via Chartmill
These stocks are the most active in today's session ↗
Via Chartmill
Unusual volume stocks are being observed in Monday's session. ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill

Frequently Asked Questions

Is Enveric Biosciences, Inc. - Common Stock publicly traded?
Yes, Enveric Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Enveric Biosciences, Inc. - Common Stock trade on?
Enveric Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Enveric Biosciences, Inc. - Common Stock?
The ticker symbol for Enveric Biosciences, Inc. - Common Stock is ENVB on the Nasdaq Stock Market
What is the current price of Enveric Biosciences, Inc. - Common Stock?
The current price of Enveric Biosciences, Inc. - Common Stock is 1.520
When was Enveric Biosciences, Inc. - Common Stock last traded?
The last trade of Enveric Biosciences, Inc. - Common Stock was at 10/21/26 02:26 PM ET
What is the market capitalization of Enveric Biosciences, Inc. - Common Stock?
The market capitalization of Enveric Biosciences, Inc. - Common Stock is 907.53K
How many shares of Enveric Biosciences, Inc. - Common Stock are outstanding?
Enveric Biosciences, Inc. - Common Stock has 908K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.